The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model

Alexander M.M. Eggermont; Domenico Bellomo; Jvalini Dwarkasing; Lisette Meerstein-Kessel; Alexander Meves

doi:10.1016/j.ejca.2021.08.042

The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model

Alexander M.M. Eggermont, Domenico Bellomo, Jvalini Dwarkasing, Lisette Meerstein-Kessel, Alexander Meves

Dermatology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	518-519
Number of pages	2
Journal	European Journal of Cancer
Volume	157
DOIs	https://doi.org/10.1016/j.ejca.2021.08.042
State	Published - Nov 2021

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/j.ejca.2021.08.042

Cite this

The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model. / Eggermont, Alexander M.M.; Bellomo, Domenico; Dwarkasing, Jvalini et al.
In: European Journal of Cancer, Vol. 157, 11.2021, p. 518-519.

Research output: Contribution to journal › Letter › peer-review

@article{27cde79082594d9887a29fc7697ecb98,

title = "The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model",

author = "Eggermont, {Alexander M.M.} and Domenico Bellomo and Jvalini Dwarkasing and Lisette Meerstein-Kessel and Alexander Meves",

note = "Funding Information: This work was supported by the National Cancer Institute of the National Institutes of Health (grant number K08 CA215105 ). ",

year = "2021",

month = nov,

doi = "10.1016/j.ejca.2021.08.042",

language = "English (US)",

volume = "157",

pages = "518--519",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model

AU - Eggermont, Alexander M.M.

AU - Bellomo, Domenico

AU - Dwarkasing, Jvalini

AU - Meerstein-Kessel, Lisette

AU - Meves, Alexander

N1 - Funding Information: This work was supported by the National Cancer Institute of the National Institutes of Health (grant number K08 CA215105 ).

PY - 2021/11

Y1 - 2021/11

UR - http://www.scopus.com/inward/record.url?scp=85117571761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85117571761&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2021.08.042

DO - 10.1016/j.ejca.2021.08.042

M3 - Letter

C2 - 34565669

AN - SCOPUS:85117571761

SN - 0959-8049

VL - 157

SP - 518

EP - 519

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

The letter responds to comment on Identification of stage I/IIA melanoma patients at high risk of disease relapse using a clinicopathologic and gene expression model

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this